ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,387,000 | -71.3% | 1,311,294 | -50.3% | 0.06% | -74.4% |
| Q2 2022 | $8,307,000 | -49.0% | 2,637,192 | 0.0% | 0.22% | -36.2% |
| Q1 2022 | $16,298,000 | -56.5% | 2,637,192 | 0.0% | 0.34% | -38.4% |
| Q4 2021 | $37,448,000 | +77.5% | 2,637,192 | 0.0% | 0.55% | +72.0% |
| Q3 2021 | $21,098,000 | -75.8% | 2,637,192 | -13.6% | 0.32% | -75.9% |
| Q2 2021 | $87,250,000 | +958.7% | 3,053,919 | +976.5% | 1.32% | +920.9% |
| Q1 2021 | $8,241,000 | – | 283,692 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,287,094 | $13,247,120 | 1.22% |
| BVF INC/IL | 8,748,629 | $27,033,264 | 0.73% |
| PFM Health Sciences, LP | 4,199,253 | $12,975,692 | 0.61% |
| Bellevue Group AG | 7,898,583 | $24,406,621 | 0.39% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,101,585 | 0.12% |
| Rock Springs Capital Management LP | 677,005 | $2,091,945 | 0.06% |
| Orbimed Advisors | 842,366 | $2,602,911 | 0.06% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,098 | 0.05% |
| Hunting Hill Global Capital, LLC | 10,000 | $30,900 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | $3,221,421 | 0.01% |